Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17188317 | 0.97 | TSHR (0.50) | TSHRCYP3A4DNM1MEN1KMT2A | |
| Ethylenediamine SCHEMBL27579634 | 0.97 | TSHR (0.55) | TSHRCYP3A4DNM1MEN1KMT2A | |
| SCHEMBL237526 | 0.97 | — | — | |
| SCHEMBL2599828 | 0.94 | DNM1 (0.55) | TSHRCYP3A4DNM1MEN1KMT2A | |
| SCHEMBL23406866 | 0.94 | TSHR (0.52) | TSHRCYP3A4DNM1MEN1KMT2A | |
| SCHEMBL5933645 | 0.94 | DNM1 (0.55) | TSHRCYP3A4DNM1MEN1KMT2A | |
| SCHEMBL309263 | 0.94 | DNM1 (0.55) | TSHRCYP3A4DNM1MEN1KMT2A | |
| SCHEMBL19262110 | 0.94 | TSHR (0.52) | TSHRCYP3A4DNM1MEN1KMT2A | |
| SCHEMBL5932795 | 0.94 | TSHR (0.52) | TSHRCYP3A4DNM1MEN1KMT2A | |
| SCHEMBL429250 | 0.94 | TSHR (0.52) | TSHRCYP3A4DNM1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220154219-A1 | GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS | THE JOHNS HOPKINS UNIVERSITY | 2022-05-19 | — | — | US | disclosed |
| US-8906979-B2 | Macrophotoinitiators | BASF SE (DE) | 2014-12-09 | — | — | US | disclosed |
| EP-2641895-A1 | Precursor of polymerizable compound | FUJIFILM Corporation (JP) | 2013-09-25 | — | — | EP | disclosed |
| US-20120178844-A1 | MACROPHOTOINITIATORS | BASF SE (DE) | 2012-07-12 | — | — | US | disclosed |
| US-7745413-B2 | Collection of traceable compounds and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2010-06-29 | — | — | US | disclosed |
| WO-2009060292-A2 | SMAC MIMETIC COMPOUNDS AS APOPTOSIS INDUCERS | UNIVERSITA'DEGLI STUDI DI MILANO (IT) | 2009-05-14 | — | — | WO | disclosed |
| US-20080176763-A1 | Collection of Traceable Compounds and Uses Thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-07-24 | — | — | US | disclosed |
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | MITSUI CHEMICALS, INC. (JP) | 2006-04-27 | — | — | US | disclosed |
| EP-1484191-A1 | REWRITABLE OPTICAL INFORMATION RECORDING MEDIUM AND RECORDING/REPRODUCING METHOD, RECORDING/REPRODUCING DEVICE | Sony Corporation (JP) | 2004-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178844-A1 | MACROPHOTOINITIATORS | CD68, CD209, MSR1 | TSHR 3272/4885CYP3A4 594/4885DNM1 3005/4885 |
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | ALPG, TRPC6, GNRHR | TSHR 1237/4885CYP3A4 3876/4885DNM1 2072/4885 |
| US-20220154219-A1 | GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS | PBK, MICA, STAT3 | TSHR 3092/4885CYP3A4 4838/4885DNM1 4014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.